Solara Active Pharma Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 10,631.9 million compared to INR 9,075.2 million a year ago. Revenue was INR 10,810.6 million compared to INR 9,214.7 million a year ago. Net loss was INR 259.4 million compared to INR 600.3 million a year ago. Basic loss per share from continuing operations was INR 7.21 compared to INR 16.71 a year ago. Diluted loss per share from continuing operations was INR 7.21 compared to INR 16.71 a year ago.